Ekramy E. Sayedahmed
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
31
Citations
532
Est. group size
~9
Recurring co-author estimate
Active years
10
Publishing since 2017
- Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses
Vaccines · 2025
- Trained ILCs confer adaptive immunity-independent protection against influenza
Journal of Virology · 2025
- A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets
Molecular Therapy — Nucleic Acids · 2025
- A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variants
npj Vaccines · 2025
- Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2
Vaccines · 2025
- Bovine Adenoviral Vector-Based Platform for Vaccine Development
Vaccines · 2025
- Induction of trained immunity by a novel Bovine adenovirus vectored tuberculosis vaccine that upregulates Dectin signaling and control of tuberculosis in mice 3049
The Journal of Immunology · 2025
- The frequency and function of nucleoprotein-specific CD8 <sup>+</sup> T cells are critical for heterosubtypic immunity against influenza virus infection
Journal of Virology · 2024
- Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector
Frontiers in Immunology · 2023
- Progress towards the Development of a Universal Influenza Vaccine
Viruses · 2022
- Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
Viruses · 2022
- A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice
Cell Reports Medicine · 2021
- Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
Clinical & Translational Immunology · 2021
- Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
Viruses · 2021
- Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Vaccines · 2020
- Vaccines×5
- Viruses×3
- Molecular Therapy — Methods & Clinical Development×2
- Journal of Virology×2
- Cell Reports Medicine×1
- Suresh K. Mittal
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Marwa Alhashimi
Medicine · Purdue University West Lafayette
- Pathum M. Weerawarna
Medicine · Indiana University
- Chelsea Bolyard
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Anna Bratasz
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile